A cost-minimization analysis of a new fixed-dose combination of dutasteride and tamsulosin compared to concomitant administration of both monotherapies for the treatment of symptomatic benign prostatic hyperplasia in Quebec, Canada

May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.915
https://www.valueinhealthjournal.com/article/S1098-3015(13)00986-8/fulltext
Section Title : Urinary/Kidney Disorders
Section Order : 470
First Page : A182
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00986-8&doi=10.1016/j.jval.2013.03.915
HEOR Topics :
Tags :
Regions :